Our Resources | Association for Accessible Medicines

Generic Prescription Drugs - Your Health. Our Commitment. #Take with Confidence

May 23, 2019 | Rachel Schwartz

AAM Statement on FTC Report on Patent Settlements

May 21, 2019 | Rachel Schwartz

AAM Statement on House Bills 965, 1499 and 938

May 17, 2019 | Rachel Schwartz

AAM Statement on the Importance of Generic and Biosimilar Quality and Robust Competition

May 16, 2019 | Rachel Schwartz

How Generic Drug Makers Are Responding to Price-Fixing Lawsuit

AAM Capitol Hill May 10 Briefing on NAFTA 2.0 with Representative Earl Blumenauer

May 13, 2019 | Erica Klinger

Highlights from the NAFTA 2.0 Congressional Briefing: The May 10 Amendments

May 13, 2019 | Rachel Schwartz

The 11th Annual Edition of AAM Access & Savings Report Finds Generic Savings Totaled $293 Billion in 2018

May 12, 2019 | Rachel Schwartz

Response to 60 Minutes May 12, 2019: AAM Statement on the Importance of Competition to Promote Accessibility and Affordability of Medicines

May 9, 2019 | AAM

2019 Generic Drug & Biosimilars Access and Savings in the U.S. Report

May 8, 2019 | Rachel Schwartz

AAM Statement on Introduction of the Affordable Prescriptions for Patients Act

May 7, 2019 | Jeff Francer

AAM Statement: Senate Judiciary Committee Hearing on Patents and Drug Prices

Fix USMCA

May 6, 2019 | Erica Klinger

Anniversary of the May 10 Trade Amendments

Apr 25, 2019 | Allen Goldberg

National Drug Take Back Day Is Saturday: Here’s What You Need to Know